NestleFOKaplanDHBarkerJ. Psoriasis. N Engl J Med2009; 361: 496–509.
2.
DingXWangTShenY, et al.Prevalence of psoriasis in China: a population-based study in six cities. Eur J Dermatol EJD2012; 22: 663–667.
3.
DowlatshahiEAWakkeeMArendsLR,et al.The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Invest Dermatol2014; 134: 1542–1551.
4.
JiangSHinchliffeTEWuT. Biomarkers of an autoimmune skin disease--psoriasis. Genomics Proteomics Bioinformatics2015; 13: 224–233.
5.
TrowbridgeRMPittelkowMREpigenetics in the pathogenesis and pathophysiology of psoriasis vulgaris. J Drugs Dermatol JDD2014; 13: 111–118.
6.
ChenS-Cde GrootMKinsleyD, et al.Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions. Arch Dermatol Res2010; 302: 113–123.
7.
PohlDAndrýsCBorskáL,et al.CC And CXC chemokines patterns in psoriasis determined by protein array method were influenced by Goeckerman’s therapy. Acta Medica (Hradec Kralove)2009; 52: 9–13.
8.
ChristophersonKHromasR. Chemokine regulation of normal and pathologic immune responses. Stem Cells Dayt Ohio2001; 19: 388–396.
9.
FerrariSMRuffilliIColaciM,et al.CXCL10 In psoriasis. Adv Med Sci2015; 60: 349–354.
10.
NedoszytkoBSokołowska-WojdyłoMRuckemann-DziurdzińskaK,et al.Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis. Postepy Dermatol Alergol2014; 31: 84–91.
11.
BarrettTWilhiteSELedouxP, et al.NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res2013; 41: D991–D995.
ShankavaramUTVarmaSKaneD, et al.Cellminer: a relational database and query tool for the NCI-60 cancer cell lines. BMC Genomics2009; 10: 277.
14.
GautierLCopeLBolstadBM,et al.Affy--analysis of Affymetrix GeneChip data at the probe level. Bioinforma Oxf Engl2004; 20: 307–315.
15.
RitchieMEPhipsonBWuD,et al.Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res2015; 43: e47.
16.
ZhaoWWangDZhaoJ,et al.Bioinformatic analysis of retinal gene function and expression in diabetic rats. Exp Ther Med2017; 14: 2485–2492.
17.
RussellCBRandHBiglerJ, et al.Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody. J Immunol Baltim Md 19502014; 192: 3828–3836.
18.
BiglerJRandHAKerkofK,et al.Cross-study homogeneity of psoriasis gene expression in skin across a large expression range. PloS One2013; 8: e52242.
19.
SubramanianATamayoPMoothaVK, et al.Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA2005; 102: 15545–15550.
20.
HänzelmannSCasteloRGuinneyJ. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics2013; 14: 7.
21.
von MeringCHuynenMJaeggiD,et al.STRING: a database of predicted functional associations between proteins. Nucleic Acids Res2003; 31: 258–261.
22.
ShannonPMarkielAOzierO, et al.Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res2003; 13: 2498–2504.
23.
JeggariAMarksDSLarssonE. Mircode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinforma Oxf Engl2012; 28: 2062–2063.
24.
LiJ-HLiuSZhouH,et al.Starbase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res2014; 42: D92–D97.
25.
ChenYWangX. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res2020; 48: D127–D131.
ValentFTullioAErrichettiE,et al.The epidemiology of psoriasis in an Italian area: population-based analysis of administrative data. G Ital Dermatol E Venereol Organo Uff Soc Ital Dermatol E Sifilogr2020; 155: 652–657.
31.
KruegerGKooJLebwohlM,et al.The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol2001; 137: 280–284.
32.
TeunissenMBKoomenCWde Waal MalefytR,et al.Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol1998; 111: 645–649.
33.
LowesMAKikuchiTFuentes-DuculanJ, et al.Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol2008; 128: 1207–1211.
34.
van der FitsLMouritsSVoermanJSA, et al.Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol Baltim Md 19502009; 182: 5836–5845.
35.
ZabaLCCardinaleIGilleaudeauP, et al.Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med2007; 204: 3183–3194.
36.
HaiderASCohenJFeiJ, et al.Insights into gene modulation by therapeutic TNF and IFNgamma antibodies: TNF regulates IFNgamma production by T cells and TNF-regulated genes linked to psoriasis transcriptome. J Invest Dermatol2008; 128: 655–666.
37.
HaiderASLowesMASuárez-FariñasM, et al.Identification of cellular pathways of “type 1,” Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis. J Immunol Baltim Md 19502008; 180: 1913–1920.
38.
DufourJHDziejmanMLiuMT,et al.IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol Baltim Md 19502002; 168: 3195–3204.
39.
AbjiFLeeK-APollockRA,et al.Declining levels of serum chemokine (C-X-C motif) ligand 10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: a new biomarker?Br J Dermatol2020; 183: 920–927.
40.
IncrocciRMcAloonJMontesanoM,et al.Epstein-Barr virus LMP2A utilizes Syk and PI3K to activate NF-κB in B-cell lymphomas to increase MIP-1α production. J Med Virol2019; 91: 845–855.
41.
RaposoRAGuptaRAbdel-MohsenM, et al.Antiviral gene expression in psoriasis. J Eur Acad Dermatol Venereol JEADV2015; 29: 1951–1957.
42.
WolkKWitteKWitteE, et al.IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis. Sci Transl Med2013; 5: 204ra129.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
